Chong Kun Dang said that the Ministry of Health of Ukraine has approved the company to conduct a phase 3 clinical trial of Covid-19 drug candidate, Nafabeltan (ingredient: nafamostat).Ukraine is the first foreign country to authorize Chong Kun Dang’s phase 3 study following the approval granted by t
Recent media reports about GC Pharma in talks with Janssen for a consigned agreement manufacturing Covid-19 vaccines have been revealed as rumors -- at least so far -- industry sources said Wednesday.The two companies acknowledged they had met but stopped short of providing detailed information over
The National Institute of Health (NIH) said Wednesday that it has found a new pathological mechanism of how ApoE4, known as a risk factor for Alzheimer's disease, aggravates the symptoms by analyzing brain tissue of dementia patients.Apolipoprotein E (ApoE) is a major transporter of extracellular li
An international research team has developed wireless and battery-free soft sensors that can continuously measure pressure and temperature of the skin to prevent pressure ulcers, also known as bedsores.Professors Park In-kyu and Oh Yong-suk of the Mechanical Engineering Department at the Korea Advan
Daewoong Pharmaceutical and Daiichi Sankyo Korea said they have found no azido methyl biphenyl tetrazole (AZBT) in 21 olmesartan drugs for high blood pressure during the recent inspection.The two companies performed the inspection following Health Canada's measure to recall treatments after detectin
The government has reaffirmed its position to return to normal life in phases, as it is difficult to maintain the current social distancing measure against Covid-19.A top health official said Tuesday that Korea might be able to adopt the "live-with-covid” regime from late October or early November."
Hanall Biopharma has begun administrating HL161 (ingredient: batoclimab) in phase 3 clinical trials conducted in China for treating myasthenia gravis. Harbour Biomed, Hanall Biopharm’s Chinese partner, is conducting clinical trials in patients with a rare long-term condition that causes muscle weakn
Korea Health Industry Development Institute (KHIDI) and the Korean Embassy in Washington will host a seminar to help domestic companies advance to Boston Biocluster at Cambridge Marriott Hotel, Boston, next Friday. The workshop will be held by the Ministry of Health and Welfare’s Medical Korea base
Daewon Pharmaceutical said that it found TG Fenon (Ingredient: fenofibrate choline) significantly reduces triglyceride levels, reaffirming its safety in phase 4 clinical trial of treating patients with hypertriglyceridemia.The company compared triglyceride reduction between patient groups that recei
Korea University Anam Hospital (KUAH) said its neurosurgery team is drawing the attention of academia with the study results of regenerative therapies, including the finding of new mediators for the stem cell therapy of ischemic stroke.The research team, led by Professor Park Dong-hyuk, has made sig
The number of patients treated for heart diseases caused by myocardial ischemia sharply grew in Korea over the past five years, significantly increasing medical expenses for their treatment, data showed.According to the National Health Insurance Service, the number of patients with ischemic heart di
Samsung Medical Center (SMC) said Monday that it has confirmed the efficacy of a combination of cytotoxic chemotherapy and Keytruda (ingredient: pembrolizumab) for esophagus cancer in the global phase 3 clinical trials.The global study, led by Professor Sun Jong-mu of the Department of Hematology an
Huons has signed an agreement with AriBio, a biotech firm specializing in medicines for neurodegenerative and infectious disease, to develop new brain disease and dementia drugs targeting the global market.The two partners signed an agreement to develop AriBio's treatment candidates for brain diseas
The mental health of young women and children has shown the most dangerous signs of all demographic groups since the outbreak of Covid-19 some one-and-a-half years ago, a lawmaker said Friday.The number of women in their 20s and 30s treated for depression and stress has continued to rise throughout
Cytiva, a U.S. company supplying raw and subsidiary materials for vaccine production, decided to invest $52.5 million in Korea until 2024 to build manufacturing facilities for global capacity expansion.Vaccine developers and research institutes from Korea and the U.S. also agreed to cooperate in dev
Access Bio signed an agreement with PharmGen Science and New Jersey’s IVY Pharma to jointly develop a biosimilar of Covid-19 mRNA vaccine as part of the global vaccine partnership between Korea and the U.S.Under the accord, Access Bio and PharmGen Science will co-invest in IVY Pharma’s research on c
Sanofi-Aventis Korea said Thursday that oral biologic Dupixent (ingredient: dupilumab) has reaffirmed its efficacy in improving the quality of life of severe asthma patients by preventing symptom exacerbations.The company presented its study results at a recent online meeting hosted by the European
The government has recently authorized Covid-19 therapy Regkirona, developed by Celltrion, more than a year-and-a-half after the nation recorded the first confirmed case in early 2020.Now the challenge for most drugmakers here is more convenient oral therapy.The Ministry of Food and Drug Safety rece
EOFlow, a company specializing in wearable drug infusion devices, continues to sophisticate its existing line of insulin pumps and expand to other areas.The company decided to invest 18 billion won ($15.3 million) to upgrade plants manufacturing EOPump, a key material for making its wearable insulin
An international research team has found that a metabolite called succinate generated by distinct gut bacteria may cause chronic bowel diseases, including inflammatory bowel diseases (IBDs), Crohn's disease (CD), and ulcerative colitis (UC).The research team -- led by Professors Cheon Jae-hee of the